Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant
- PMID: 33159210
- DOI: 10.1093/cid/ciaa1486
Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant
Abstract
Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission.
Keywords: Clostridioides difficile; FMT; STEC; Shiga toxin-producing E. coli; fecal microbiota transplantation.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Fecal Microbiota Transplantation: Tales of Caution.Clin Infect Dis. 2021 Jun 1;72(11):e881-e882. doi: 10.1093/cid/ciaa1492. Clin Infect Dis. 2021. PMID: 32991697 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
